2023

LTP Hav ikon

Seas and oceans

LTP2 Muliggjørende og industrielle teknologier ikon

Enabling and industrial technologies

Portefølje Muliggjørende teknologier ikon

Enabling technologies

Portefølje Samisk ikon

Samisk

Portefølje Industri og tjenestenæringer ikon

Industry and services

android-chrome-192x192

Life sciences

Portefølje Naturvitenskap og teknologi ikon

Natural sciences and technologies

Portefølje Humaniora og samfunnsvitenskap ikon

Humanities and social sciences

Portefølje Global utvikling og internasjonale relasjoner ikon

Global development and international relations

Portefølje Demokrati, styring og fornyelse ikon

Democracy, administration and renewal

Portefølje Utdanning og kompetanse ikon

Education and competence

Portefølje Velferd, kultur og samfunn ikon

Welfare, culture and society

Portefølje Helse ikon

Health

Portefølje Hav ikon

Oceans

Portefolje Petroleum Ikon

Petroleum

Portefølje Klima- og polarforskning ikon

Climate and polar research

Portefølje Landbasert mat, miljø og bioressurser ikon

Land-based food, the environment and bioresources

Portefølje Energi, transport og lavutslipp ikon

Energy, transport and low emissions

LTP Climate

Enhancing competitiveness and innovation capacity

Renewal in the public sector

Public sector renewal and better public services

Internationalization

Societal security and social cohesion in a globalised world

LTP Climate, environment and environmentally friendly energy

Climate, the environment and clean energy

Professional environment

Developing academic and research communities of outstanding quality

 An innovative business community

Frontpage Image

Marine icon

Petroleum og mineraler

Velferdstjenester

Portefølje Livsvitenskap ikon

LTP2 Styrket konkurransekraft og innovasjonsevne ikon

LTP2 Utvikle fagmiljøer av fremragende kvalitet

LTP2 Samfunnssikkerhet og samhørighet ikon

LTP2 Fornyelse i offentlig sektor ikon

LTP2 Klima, miljø og miljøvennlig energi ikon

Forsidebilde optimalisert

project-bank-technical

Et innovativt næringsliv ikon

Muliggjørende teknologier bakgrunn

Marin bakgrunnsbilde

Marin ikon

Forsidebilde

About Text Queries

No thematic area or topic related to the project

has received funding in the programme period

No popular science description is available

have received funding in the programme period

The project with project number {{project number}} was not found

Statistics

Prosjektbanken presenterer statistikk og informasjon om prosjekter med finansiering fra Forskningsrådet fra 2004. Statistikken er fordelt på blant annet tema, år, geografi og organisasjon. Prosjektbanken gir også detaljert informasjon om de enkelte prosjektene.

...or see the summary and other information about the projects you have selected

Technical description

Woops, something went wrong. Please refresh the page. If the error persists, please contact us.

We could not find what you were looking for

All long term plan objectives

En god beskrivelse av denne siden for søkemotoroptimalisering

See statistics related to this LTP objective

See projects related to this LTP objective

related to this LTP objective have received grants

has been granted to projects related to this LTP objective

has been granted to projects related to this portfolio

related to this portfolio have received grants

Portfolios

About Prosjektbanken

Forside

How the grants are distributed between organisations, counties, subject areas etc....

Here are some examples of searches you can perform in the Project Databank

Kunnskapsdepartementet – sektorovergripende

Medisin og helsefag

Oslo

LTP2 Fagmiljøer og talenter

LTP2 Fornyelse i offentlig sektor

LTP2 Helse, forebygging og behandling

LTP2 IKT og digital transformasjon

LTP2 Innovasjon i stat og kommune

LTP2 Muliggjørende og industrielle teknologier

LTP2 Styrket konkurransekraft og innovasjonsevne

Offentlig sektor

Portefølje Demokrati, styring og fornyelse

Portefølje Helse

Portefølje Livsvitenskap

Portefølje Muliggjørende teknologier

Frittstående prosjekter

Innovasjonsprosjekt

Politikk- og forvaltningsområder

Fornyelse og innovasjon i offentlig sektor

Anvendt forskning

Digitalisering og bruk av IKT

Grunnforskning

Helse

Organisasjon og ledelse

Tjenesterettet FoU

Next Arctic Rush? Critical Materials for the Energy Transition

Intestinal epithelial cells: Central coordinators in Inflammatory Bowel Disease and targets for treatment

Chronic wasting disease  prions from Norwegian cervids: Assessing the pathogenesis, shedding, spillover and zoonotic potential

Privacy-aware Edge and Data Subjects

Regional adipose tissue depots in Atlantic salmon and their importance to fish health

Ammonia Production via Electrocatalytic Processes (AmPEP)

(DigiFishent): Digital phenotyping for more feed and resource efficient Atlantic salmon

Single Cell Data-derived European Study for Personalised Management of Chronic Kidney Disease (CKD) in Children and Adolescents

Use of welfare technology in Tromsø municipality.

Læring i algoritmenes tidsalder (LAT) – En innovasjon for didaktisk bruk av kunstig intelligens.

Nanoformuleringer for ny kombinasjonsbehandling: Ny anvendelse av medisiner for forbedret og synergistisk behandlingseffekt

Midlene fra NANO2021-Nanoteknologi og nye materiale fordelt på år

Midlene fra NANO2021-Nanoteknologi og nye materiale fordelt på fylker

Midlene fra NANO2021-Nanoteknologi og nye materiale fordelt på fagområde

Senior Research Scientist

A large number of both existing and newly developed medicines are poorly water soluble or unstable and therefore difficult to deliver efficiently to the right place in the body. Many highly potent medicines will therefore never benefit the patient. 

NaDeNo is a Norwegian nanopharmaceutical spin-off company from SINTEF based on more than ten years of research on nanomedicine. NaDeNo's technology solution makes it possible to pack large amounts of active medicine into nanoparticles, which in turn transport the medicine to the disease site in the body in a safer and more efficient way. 

In this innovation project, NaDeNo will develop new drug candidates by combining several different cancer drugs in one product using nanoparticles. This will enable precisely controlled co-delivery of new drug combinations with a potentially much better efficacy compared to separately administred drugs.

The project will be carried out in close collaboration with SINTEF and the Norwegian Radium Hospital/Oslo University Hospital.

NaDeNo is a Norwegian nano-pharmaceutical spin-off company from SINTEF based on > 10 years of research at SINTEF. Our mission is to use nanoformulation as a broad applicable approach to overcome drug delivery hurdles with a vision to unleash the potential of hard-to-deliver drugs and obtain improved treatment effect with less side effects. 
The innovation forming the basis of this project is a technology for combining multiple drugs in one product with a significantly improved therapeutic and synergistic potential compared to separately administrated drugs. The innovation will enable precisely controlled co-delivery of new drug combinations. The need for better drug delivery solutions has been confirmed by clinical experts and drug developers. The outcome of the project will be new products for treatment of cancer indications with high unmet medical needs, and will trigger substantial market and IP opportunities for NaDeNo. 

Combination therapies are designed to prevent drug resistance and achieve therapeutic synergy. However, co-delivery of multiple drugs requires delivery of both drugs at the correct doses, to the correct place. This is challenging to achieve with separately administered drugs. Packaging multiple drugs into one nanoparticle product can enable simultaneous drug release in precisely balanced ratios and rates, and in selectively targeted tissues and cells. 
The key to the realization of the innovation is NaDeNo’s proprietary nanoformulation technology designed for encapsulation of water insoluble drugs. The drugs to be investigated are well known with proven efficacy and complementary mode-of-actions, but have so far had limited clinical use due to low water solubility and/or high toxicity. The NaDeNo innovation opens for reviving these drugs towards novel use and novel combinations and represents a completely new way of using already existing cancer drugs.

Nano-co-formulations for new combination therapy: Reviving hard-to-deliver drugs for improved and synergistic treatment effect

Hva kjennetegner samarbeid i helsefelleskap som bidrar til pasientens opplevelse av helhet og sammenheng i digital hjemme oppfølging?

0 projects

Display

Order by

Year